Trial Profile
Phase I trial of Radspherin.
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 17 Apr 2018
Price :
$35
*
At a glance
- Drugs Radspherin (Primary)
- Indications Peritoneal cancer
- Focus Adverse reactions
- 17 Apr 2018 New trial record
- 13 Apr 2018 According to the Oncoinvent media release, company plans to start this trial early next year.